PA
RJF icon

PharVision Advisers’s Raymond James Financial RJF Stock Holding History

PharVision Advisers’s Portfolio RJF Stock Details RJF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,664
Closed -$267K – 532
2025
Q4 		$267K Buy
+1,664
New +$269K 0.14% 346
2025
Q2 		– Sell
-1,739
Closed -$242K – 403
2025
Q1 		$242K Buy
+1,739
New +$270K 0.34% 145

Other funds holding RJF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

PharVision Advisers's RJF Position: Q1 2026 in Review

PharVision Advisers sold out of Raymond James Financial (RJF) in Q1 2026, closing a stake of 1,664 shares — an estimated $267K sold.

PharVision Advisers first reported a position in RJF in Q1 2025 and held it in 2 quarters. The position peaked at $267K in Q4 2025. 918 funds tracked by Wall St. Rank hold RJF as of Q1 2026.

  • PharVision Advisers reported no remaining Raymond James Financial position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 1,664 Raymond James Financial shares in Q1 2026, an estimated $267K.
  • PharVision Advisers first reported a position in Raymond James Financial in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Raymond James Financial position peaked at $267K in Q4 2025.
  • 918 funds tracked by Wall St. Rank held Raymond James Financial as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.